Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Melar Acquisition I | MACIU | Nov 22, 2024 | 10.14 | 0.00 |
Melar Acquisition I | MACI | Nov 22, 2024 | 10.03 | -0.16 |
Melco Resorts & Entertainment ADR | MLCO | Nov 22, 2024 | 5.95 | -1.82 |
MercadoLibre | MELI | Nov 22, 2024 | 2 005.00 | +1.87 |
Mercantile Bank | MBWM | Nov 22, 2024 | 50.39 | +2.75 |
Mercer International | MERC | Nov 22, 2024 | 6.40 | +0.63 |
Merchants Bancorp | MBIN | Nov 22, 2024 | 41.09 | +4.29 |
Merchants Bancorp B | MBINO | Nov 22, 2024 | 25.40 | +0.04 |
Merchants Bancorp C Pref | MBINN | Nov 22, 2024 | 22.62 | +1.85 |
Merchants Bancorp Pref D | MBINM | Nov 22, 2024 | 26.25 | +0.81 |
Merck & Co | MRK | Nov 22, 2024 | 99.18 | -0.68 |
Mercurity Fintech | MFH | Nov 22, 2024 | 4.99 | +21.71 |
Mercury General | MCY | Nov 22, 2024 | 77.27 | +1.06 |
Mercury Systems | MRCY | Nov 22, 2024 | 40.94 | +2.40 |
Mereo BioPharma ADR | MREO | Nov 22, 2024 | 3.72 | +1.09 |
Meridian | MRBK | Nov 22, 2024 | 15.50 | +6.90 |
MeridianLink | MLNK | Nov 22, 2024 | 22.90 | +2.10 |
Merit Medical Systems | MMSI | Nov 22, 2024 | 105.33 | +0.29 |
Meritage Homes | MTH | Nov 22, 2024 | 184.44 | +3.80 |
Merrill Lynch & Co. | IPB | Nov 22, 2024 | 25.80 | 0.00 |
Mersana Therapeutics | MRSN | Nov 22, 2024 | 2.04 | +3.03 |
Merus N.V | MRUS | Nov 22, 2024 | 45.49 | +2.56 |
Mesa Air Group | MESA | Nov 22, 2024 | 0.87 | +0.62 |
Mesa Laboratories | MLAB | Nov 22, 2024 | 109.09 | +8.16 |
Mesa Royalty Trust | MTR | Nov 22, 2024 | 7.26 | +0.28 |
Mesabi Royalty Trust | MSB | Nov 22, 2024 | 26.03 | -1.92 |
Mesoblast ADR | MESO | Nov 22, 2024 | 10.11 | -0.69 |
Meta Materials | MMAT | Nov 22, 2024 | 0.64 | 0.00 |
Meta Platforms A | META | Nov 22, 2024 | 559.14 | -0.70 |
Metagenomi | MGX | Nov 22, 2024 | 1.89 | +3.85 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.